|
|
Home > Healthcare > Pharmaceutical > General Pharmaceutical
Kuwait Pharmaceuticals and Healthcare Report Q3 2009
|
|
- Executive Summary
- SWOT Analysis
- Kuwait Pharmaceuticals And Healthcare Industry SWOT
- Kuwait Political SWOT
- Kuwait Economic SWOT
- Kuwait Business Environment SWOT
- Pharmaceutical Business Environment Ratings
- Table: Regional Business Environment Ratings, Q309
- Limits Of Potential Returns
- Risks To Realisation Of Returns
- Kuwait - Market Summary
- Regulatory Regime
- Foreign Direct Investment Regulations
- Intellectual Property Regime
- IP Shortcomings
- Pricing And Reimbursement Regime
- Public Procurement Of Medicines
- Regional Harmonisation
- Free Trade Agreements
- Industry Developments
- Epidemiology
- Healthcare Sector
- Primary Care
- Secondary Care
- Recent Public Health Developments
- Healthcare Insurance
- Healthcare Reforms
- Regional Developments
- International Collaboration
- Pharmaceutical Sector
- Research And Development
- Biotechnology Sector
- Medical Devices
- Table: Diverse Potential For Product Launches: New Products For 2009
- Industry Forecast Scenario
- Overall Market Forecasts
- Table: Kuwait - Drug Expenditure Indicators,
- Key Growth Factors - Industry
- Table: Kuwait - Health Expenditure Indicators
- Key Growth Factors - Macroeconomic
- Table: Kuwait - Economic Activity, 2006-2013
- Prescription Drug Market Forecast
- Table: Kuwait - Prescription Market Indicators, Historical Data And Forecasts (KWDmn unless otherwise stated)
- Patented Drug Market Forecast
- Table: Kuwait - Patented Market Indicators
- Generic Drug Market Forecast
- Table: Kuwait - Generics Market Indicators, Historical Data And Forecasts
- OTC Drug Market Forecast
- Table: Kuwait - OTC Market Indicators, Historical Data And Forecasts (KWDmn unless otherwise stated)
- Export/Import Drug Market Forecasts
- Table: Kuwait - Pharmaceutical Trade Indicators, Historical Data And Forecasts (US$mn unless otherwise stated)
- Medical Devices Forecast
- Table: Kuwait’s Medical Devices Market, 2003-2013
- Other Healthcare Data
- Table: Kuwait - Other Healthcare Indicators, Historical Data And Forecasts, 2003-2013
- Key Risks To BMI Forecasts
- Competitive Landscape
- Company Profiles
- Multinationals
- Novartis
- Sanofi-Aventis
- Pfizer
- GlaxoSmithKline
- Merck & Co
- Johnson & Johnson
- Indigenous Players
- Advanced Technology Company
- Bader Sultan & Bros
- Safwan Trading And Contracting Company
- Country Snapshot: Kuwait Demographic Data
- Section 1: Population
- Table: Demographic Indicators, 2005-2030
- Table: Rural/Urban Breakdown, 2005-2030
- Section 2: Education And Healthcare
- Table: Education, 2002-2005
- Table: Vital Statistics, 2005-2030
- Section 3: Labour Market And Spending Power
- Table: Employment Indicators, 1997-2006
- Table: Consumer Expenditure, 2000-2012
- BMI Forecast Modelling
- How We Generate Our Pharmaceutical Industry Forecasts
- Pharmaceutical Business Environment Ratings Methodology
- Ratings Overview
- Table: Pharmaceutical Business Environment Indicators
- Weighting
- Table: Weighting Of Components
- Sources
|
Similar Products
• United States Type 2 Diabetes Market
Published Nov 2009 by Intellent
• Snapshots Poland Pharmaceuticals 2009
Published Nov 2009 by Snapdata International Group
• Snapshots Venezuela Pharmaceuticals 2009
Published Nov 2009 by Snapdata International Group
• Snapshots Spain Pharmaceuticals 2009
Published Nov 2009 by Snapdata International Group
• Snapshots South Africa Pharmaceuticals 2009
Published Nov 2009 by Snapdata International Group
• Snapshots Hungary Pharmaceuticals 2009
Published Nov 2009 by Snapdata International Group
• Nigeria Pharmaceuticals and Healthcare Report Q1 2010
Published Nov 2009 by Business Monitor International
• Kenya Pharmaceuticals and Healthcare Report Q1 2010
Published Nov 2009 by Business Monitor International
• Company Financials: Bayer AG
Published Nov 2009 by Datamonitor
• Merck & Co. Performance, Products, Pipeline and Potential
Published Nov 2009 by Espicom Healthcare Intelligence
|
|
|
|
0 items
